INO
Inovio Pharmaceuticals Inc
1.20$
+2.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -75.9% | -75.9% | -173.1% | -188.0% | -2,616.9% | -3,413.0% | -582.7% | -225.7% | -203.1% | -239.5% | -530.4% | -154.4% | -194.3% | -201.7% | -541.6% | -114.2% | -285.2% | -30.7% | -176.9% | -149.7% | -241.3% | -2,379.7% | -2,401.5% | -12,154.3% | -2,106.9% | -14,947.6% | -47,795.0% | -135,637.2% | |
| 4.8% | 4.8% | 11.2% | 14.7% | 326.8% | 725.7% | 49.1% | 14.6% | 26.3% | 19.9% | 47.3% | 18.4% | 34.3% | 20.5% | 48.4% | 15.6% | 15.0% | 4.7% | 8.7% | 8.2% | 16.4% | 134.2% | 62.4% | 266.6% | 53.6% | 421.1% | 1,437.4% | 4,574.1% | |
| – | – | 4.5% | 5.1% | 55.6% | 212.3% | 35.4% | 2.1% | 40.4% | 35,418,156.9% | 54.2% | 23.7% | 19.1% | 16.9% | 32.7% | 13.9% | 51.9% | 15.2% | 29.6% | 31.0% | 35.0% | 265.1% | 211.1% | 1,484.0% | 219.8% | 1,330.8% | 3,028.7% | 5,747.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 10.9% | 4.3% | 2.1% | 59.2% | 13.7% | 26.8% | 36.8% | 33.7% | 423.9% | 1,294.1% | 1,547.2% | 292.5% | – | – | – | |
| -2.4% | -2.4% | 2.6% | -7.5% | 122.8% | 48.3% | 277.8% | -23.0% | 84.9% | -13.3% | -8.9% | -40.3% | 59.4% | -13.0% | -28.9% | 12.4% | 20.7% | 33.6% | -1.5% | 6.9% | 15.4% | -86.2% | -959.0% | 2,837.1% | 193.3% | -1,233.1% | -1,223.8% | -14,108.3% | |
| 6.0% | 6.0% | 5.7% | 5.9% | 215.7% | 74.0% | 8.8% | 5.2% | 39.4% | 13.4% | 27.8% | 1.8% | 5.0% | 1.6% | 5.9% | 1.3% | 13.2% | 6.9% | 11.1% | 24.4% | 6.8% | 24.0% | 20.5% | 69.4% | 9.4% | 38.6% | 224.0% | 437.2% | |
| – | -9.6% | -15.5% | -76.1% | -205.3% | -422.4% | -37.6% | -56.3% | -463.2% | -59.3% | 139.0% | 15.9% | 186.1% | -111.3% | 128.1% | -68.6% | -342.5% | -135.1% | 46.0% | -65.9% | 139.2% | -220.0% | -793.3% | -9,879.9% | 1,067.9% | 10,499.4% | 47,792.5% | 21,485.6% | |
| – | – | – | – | – | – | 23.7% | 11.2% | 3.8% | 0.5% | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 2,267.5% | 52.0% | – | – | – | – | – | |
| – | – | – | 29.0% | – | – | – | – | – | – | – | – | – | 286.0% | 129.3% | 244.2% | 566.2% | 208.3% | 12,157,758.7% | 223.5% | -2.0% | -21.7% | -54.4% | -259.8% | -13.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 275.5% | 230.8% | 319.7% | 2,289.2% | 2.3% | 0.0% | 0.0% | 0.0% | -7,538.3% | 0.0% | |
| 83.1% | 83.1% | 258.5% | 128.9% | 2,424.1% | 19,463.2% | 999.8% | 268.7% | 409.2% | 339.1% | 579.7% | 313.6% | -157.7% | 286.0% | 129.3% | 391.3% | 693.0% | 207.9% | 22.0% | 226.6% | 101.8% | 2,563.2% | 6,278.0% | 11,917.1% | 797.5% | 600.4% | 23,639.1% | 81,187.1% | |
| -3.6% | -3.6% | 70.0% | -135.2% | -494.8% | 15,627.9% | 379.5% | -13.2% | -255.0% | 40.1% | 184.2% | 177.4% | -167.6% | -27.0% | -284.2% | 208.5% | 65.3% | 42.1% | -108.8% | 11.0% | -0.3% | -36.4% | 3,083.6% | -10,118.8% | -241.8% | -3,848.3% | 23,651.4% | -32,964.5% | |
| -81.9% | -81.9% | -178.8% | -193.9% | -2,832.6% | -3,487.0% | -591.5% | -230.9% | -242.4% | -252.9% | -558.3% | -156.2% | -199.3% | -203.3% | -547.5% | -115.5% | -298.4% | -37.5% | -188.0% | -174.1% | -248.1% | -2,403.7% | -2,422.0% | -12,223.6% | -2,116.3% | -14,986.2% | -48,019.1% | -136,074.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.